Is Edge-to-Edge Treatment with PASCAL Effective at 3 Years?

Mitral regurgitation is the most common valvular heart disease. Its cause is most frequently functional or secondary dysfunction (functional mitral regurgitation, FMR) compared with degenerative mitral regurgitation (DMR), which is associated with decreased ventricular function, hospitalization for heart failure, and mortality.

¿Es efectivo el tratamiento borde a borde con PASCAL a 3 años?

While medical treatment is effective over extended periods, a significant number of patients cannot undergo surgery due to high or extreme surgical risk.

Edge-to-edge treatment has emerged as a valid alternative with promising results compared to comprehensive medical treatment, as shown in the COAPT Study. However, until now, only this analysis and other smaller studies are available, especially regarding long-term outcomes.

The CLASP Study included 124 patients with symptomatic severe mitral regurgitation, of whom 85 had FMR and 39 had DMR.

Major adverse events (MAEs) were assessed at 3 years. MAEs were defined as the presence of cardiovascular mortality, stroke, acute myocardial infarction, need for dialysis, severe bleeding, and device-related reintervention.

Read also: Relationship between Distal Vessel Quality and Outcomes in the Treatment of Chronic Total Occlusions.

Mean age was 75 years, and 55% of subjects were male. About 83% of patients had hypertension, 36% had diabetes, 12% had suffered a prior stroke, 63% had atrial fibrillation, 30% had impaired renal function, 24% had pulmonary hypertension, 35% had moderate to severe tricuspid insufficiency, and NT BNP levels were 4,148 pg/mL.

At 3 years, the MAEs rate was 26.6% (30.6% for FMR and 17.9% for DMR); for cardiovascular mortality, it was 14.5% (18.8% for FMR and 5.1% for DMR). About 4.0% of patients had experienced a stroke (4.7% for FMR and 2.6% for DMR), 3.2% had experienced an acute myocardial infarction (2.4% for FMR and 5.1% for DMR), and 2 patients had required reintervention.

The 3-year survival rate was 74.6% (66.0% for FMR and 91.7% for DMR), and the rate for freedom from rehospitalization for heart failure was 73.1% (63.9% for FMR and 91.1% for DMR).

Read also: Cerebrovascular Events in the COAPT Study.

The annualized hospitalization rate at 3 years decreased by 85%, from 1.17 before the procedure to 0.18 (81% for FMR and 96% for DMR; in both types of mitral regurgitation, p <0.001), and there was a significant improvement in functional class. Additionally, there was a significant reduction in ventricular volume and mitral regurgitation at 30 days, which was maintained at 3 years for both DMR and FMR.

Conclusion

The 3-year results of the CLASP Study demonstrate the durability and favorable evolution of the PASCAL System in symptomatic patients with severe mitral regurgitation. These results further support the use of the PASCAL System as a valuable therapy for patients with symptomatic mitral regurgitation.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Three‐year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study.

Reference: Konstantinos Spargias, et al. Catheter Cardiovasc Interv. 2023;102:145–154.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...